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Edited by Robert BaroukiAbstract The hypothesis that the cytosolic RNase inhibitor
(cRI) has a role in the protection of the cellular redox homeosta-
sis was investigated testing the eﬀects of oxidants and anti-oxi-
dants on normal, primary endothelial HUVE cells, and
malignant HeLa cells, before and after their engineering into
cRI-deprived cells. We found that cRI plays an important, pos-
sibly a key, physiological role in the protection of cells from
redox stress, as demonstrated by decreased GSH levels as well
as increased oxidant-induced DNA damage in cRI deprived cells.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The cytosolic RNase inhibitor [1,2] is an ubiquitous leucine-
repeat protein very rich in Cys residues, which binds with
extremely high aﬃnity monomeric RNases of the pancreatic-
type, RNase A family, thus fully inhibiting their ribonucleoly-
tic activity.
The hypothesis has been proposed that the physiological role
of cRI is that of a ‘‘sentry’’ to protect RNA from RNases
which might enter the cytosol [2]. This hypothesis is supported
by two lines of evidence: (i) naturally cytotoxic RNases are not
inhibited by cRI; (ii) non-cytotoxic RNases strongly inhibited
by cRI become cytotoxic when they are engineered into rela-
tively cRI-resistant RNases [3].
Other data however are in contrast with the ‘‘sentry’’
hypothesis, as it has been found that the virtual absence of
cRI in HeLa cells, obtained through RNA silencing, does
not render these cells sensitive to non-cytotoxic RNases [4].
Moreover, there are RNases which have been shown to be
cytotoxic [5], yet they bind cRI with high aﬃnity [6].
Based on the prospect that the biological role of cRI is still
unclear, we focused our attention on the possibility that cRI,
with its high content of Cys residues, could act also to protect*Corresponding author. Fax: +39 081679159.
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doi:10.1016/j.febslet.2007.01.072cells against oxidative damage. To verify this hypothesis, based
on an early intuition of Hofsteenge and coworkers [7], and in
line with recent results [8,9], we propose here a novel experi-
mental approach, based on testing the eﬀects of oxidants and
anti-oxidants in cells in which cRI expression has been hin-
dered. The data we obtained indicate that cRI plays the role,
possibly physiological, of a defensive system against oxidative
stress.2. Materials and methods
2.1. Materials
RNase A (type XII), diethylmaleate (DEM), N-acetyl-cysteine
(NAC) and anti-actin antibody were purchased from Sigma. The
anti-GAPDH antibody was obtained from Ambion. Complete prote-
ase inhibitor was purchased from Roche. Plasmid pU6-cRI-neor was
prepared as described [4]. RNase A-Sepharose (Amersham Biosci-
ences) was prepared as described by the manufacturer instructions.
2.2. Cell culture and transfection
HeLa cells (ATCC) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (Sigma) supplemented with 10% fetal bovine serum (Hy-
Clone). HeLa sub-clones with undetectable expression of cRI were cul-
tured with the same medium supplemented with 0.6 mg/ml G418
(Invitrogen). HUVE cells (Cambrex) were cultured in EGM-2 Bullet
kit (Cambrex). For transfections, cells (1 · 105/well) were grown in
6-well plates and transfected with 1 lg of plasmid DNA in 5 ll of
Lipofectine (Invitrogen) as described by the manufacturer instructions.
DEM and NAC were added directly to the culture medium as follows:
5 mM NAC (90 min before exposure to DEM), 0.5 mM DEM. After
6 h at 37 C, cells were collected and lysed by sonication in 0.25 M su-
crose, 2 mM DTT in PBS and Complete Inhibitor of proteases.
Several nucleotide sequences from cRI gene (GenBank Accession
No. M22414) were tested for constructing the plasmid containing the
DNA encoding a siRNA for eﬀective silencing of cRI protein. As
detailed in a previous paper [4], and suggested by the plasmid manufac-
turer (Ambion), the nucleotide sequence 430–449 was identiﬁed as the
most eﬀective sequence, both for its GC content and its extended dis-
tance from the mRNAAUG. The nucleotide sequence for constructing
the plasmid encoding a siRNA against the actin gene (GenBank Acces-
sion No. NM_001101) included the segment 474–493 from the gene
sequence.
2.3. RNase A-Sepharose binding
To evaluate cRI in cell lysates, aliquots of lysates were incubated
with RNase A-Sepharose resin for 30 min at room temperature.
Unbound cRI was separated by centrifugation at 500g for 5 min.
The resin was washed twice with 0.5 M NaCl and 2 mM DTT in
PBS, eluted by boiling the resin reagent with 1% b-mercaptoethanol,
2% SDS, 0.5 M NaCl and 2 mM DTT in PBS, and run on SDS–blished by Elsevier B.V. All rights reserved.
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acetic acid before loading on SDS–PAGE. Cell lysates, blottings and
antisera were prepared as described in [4].
2.4. GSH and thiol assay
Intracellular GSH content was determined as described in [15] with
minor modiﬁcations: cells were washed twice in PBS, harvested and
centrifuged at 1200g for 10 min at 4 C. The pellets were lysed by add-
ing 100 ll of 3% perchloric acid for 15 min and centrifuged at 20000g
for 10 min at 4 C. To the supernatant, neutralized with 900 ll of
0.1 M NaH2PO4, 5 mM EDTA, glutathione reductase (1 lg/ml) and
NADPH (0.21 mM) were immediately added and the mixture was incu-
bated 10 min at 37 C. GSH content was measured by adding 600 lM
DTNB (5,5 0-dithio-bis(2-nitrobenzoic acid)), and the absorbance of the
resulting thionitrobenzoate was read at 412 nm. For measuring protein
concentration, the pellets lysed with perchloric acid were resuspended in
1 M NaOH and tested with the Bradford method (BioRad).
Free thiols from small compounds and protein thiols were deter-
mined with the colorimetric assay acquired from Molecular Probes fol-
lowing the manufacturer’s instructions.
2.5. Comet assay
DNA damage was determined using the Comet assay [16], with
modiﬁcations. Brieﬂy, cells were washed with PBS, trypsinized, re-sus-
pended in PBS, and combined with LM-agarose at a ratio of 1:8
(cells:agarose). Electrophoretic runs and qualitative and/or quantitative
analyses were carried out according to the Trevigen protocol. Quantita-
tive analyses of the results were obtained by using the NIH Image soft-
ware. Data are reported as the ratio between tail and nucleus areas.Fig. 1. Silencing of cRI in HUVE and HeLa cells. Western blot
analyses of lysates from HUVE (panels A–C) and HeLa (panel D)
cells. Histograms were obtained by phosphorimaging analyses using
GAPDH as an internal standard. Panel A: lysates from HUVE cells
before transfection (lane 2), 24 h (lane 3) and 72 h (lane 4) after
transfection with plasmid pU6-cRI-neor; lane 1, cRI as a standard.
Panel B: lysates from HUVE cells transfected for 72 h with an empty
vector (lane 1), the pU6-actin vector encoding the si-RNA against the
actin gene (lane 2), the pU6-cRI vector encoding the si-RNA against
the cRI gene (lane 3). Western blots were carried out with anti-cRI
antiserum (top row), anti-actin antibody (middle row), and anti-
GAPDH antibody ( bottom row). The histograms reported in Panel B
illustrate the cRI levels; those in Panel C illustrate the actin levels.
Panel D: lysates from wild-type HeLa cells (lane 2), clone B (lane 3)
and clone O (lane 4). In lane 1 cRI as a standard.3. Results and discussion
3.1. Silencing of cRI in HUVE and HeLa cells
HUVE cells were transfected with plasmid pU6-cRI-neor,
containing theDNA template encoding a siRNAwhich has been
shown to eﬀectively and speciﬁcally silence human cRI mRNA
[4]. The eﬀects of transfection were analyzed at the protein level
with an anti-cRI antibody using GAPDH as an internal stan-
dard (Fig. 1A). Silencing of the cRI protein was about 45% or
60% 24 or 72 h after transfection (Fig. 1A, lanes 3 and 4).
To verify the speciﬁcity of the silencing results, negative and
positive control experiments were run on HUVE cells (see
Fig. 1, panels B and C). The former were carried out by trans-
fecting cells with an empty vector, deprived of the DNA encod-
ing siRNA. Positive controls were performed by silencing in
the same cells actin mRNA. Lysates were tested by Western
blotting with anti-cRI antiserum [4] and anti-actin and
GAPDH antibodies. In the experiments with the empty vector
(see Fig. 1, panel B, lane 1) the levels of cRI, or actin were not
aﬀected; in the actin and cRI silencing tests, actin and cRI
expressions were speciﬁcally silenced by more than 60% (see
Fig. 1B, lanes 2 and 3).
It should be noted that stable transfectants of HUVE cells
were not obtained, and transient transfections of HUVE cells
with pU6-cRI-neor were found to be less eﬀective than with
HeLa cells. These ﬁndings could be related to the much higher
level of cRI in HUVE cells, in which 84.2 ± 5 pg of cRI/lg
total proteins were found, almost 3.5-fold more cRI than in
HeLa cells (see Table 1).
For silencing the expression of cRI in HeLa cells we used
stable clones B and O subcloned from the previously investi-
gated clone 11 [4]. About 70% and 95% silencing of the cRI
protein was obtained for subclones B and O, respectively
(Fig. 1D, lanes 3 and 4). Quantitative data on silencing are tab-
ulated in Table 1.3.2. Antioxidant activity of the cytosolic RNase inhibitor
The importance for cRI molecular integrity of the integrity
of all its numerous cysteine residues has been ascertained.
Either substitution [10] or oxidation [7] of Cys residue(s) can
inactivate cRI. To verify the cRI antioxidant role we investi-
Table 1
GSH, thiol and cRI contents in HeLa and HUVE cells
Cell line pg cRI/lg proteins nmol GSH/mg proteins nmol free thiols/mg proteins nmol protein thiols/mg proteins
HeLa 24.3 ± 1.9 2.1 ± 0.3 25.2 ± 4.5 16.6 ± 5.5
Clone B 7.65 ± 0.5 1.2 ± 0.3
Clone O 0.07 ± 0.01 0.3 ± 0.1 13.7 ± 0.02 15.3 ± 6.7
HUVEC 84.2 ± 5 0.8 ± 0.3 11.6 ± 6 11.3 ± 6.7
HUVEC cRI 33.7 ± 1 Not detectable
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bations induced in HeLa cells exposed to 100 or 500 lM dieth-
ylmaleate (DEM), a GSH depleting agent. DEM was preferred
as an oxidizing agent since it induces an indirect oxidative
stress, by forming GSH/DEM complexes in the presence of
glutathione transferases [11]. Furthermore, it yields oxidized
intracellular conditions much milder than when H2O2 is used
as an oxidant [12].
The cRI protein was determined in cell lysates by Western
blotting with an anti-cRI antiserum, and its activity was tested
by analyzing its ability to bind to an RNase A-Sepharose aﬃn-
ity reagent. cRI from untreated cells was found to bind totally
to RNase A-Sepharose (Fig. 2, lane 6), whereas lysates from
oxidized cells contained: (i) an increasing fraction of cRI which
did not bind to the resin, depending on DEM concentration
(see Fig. 2, lanes 3 and 4); (ii) a corresponding decreasing frac-
tion of bound protein (see Fig. 2, lanes 7 and 8). Thus, a con-
clusion could be drawn from these data: that an oxidized
intracellular environment, due to DEM-induced GSH deple-
tion, results in cRI inactivation.
These results led us to focus on the hypothesized role of cRI,
as part of a thiol pool, in the control of intracellular redox con-
ditions. Therefore, we measured glutathione, the major intra-
cellular scavenging molecule, in HeLa and HUVE cell
systems, and compared its levels with the corresponding levels
of cRI. In transfected HeLa cells, in which cRI was silenced
(clones B and O), a strong decrease in GSH content was found,Fig. 2. Eﬀects of DEM treatment on HeLa cells. Western blot analyses
with anti-cRI antibody, and corresponding histograms, of cRI levels in
lysates of wild type and oxidized HeLa cells analyzed with RNase A-
Sepharose as an aﬃnity reagent. In lanes 1 and 5: cRI as a standard. In
lanes 2 and 6, cRI protein unbound or eluted, respectively, from the
aﬃnity reagent before exposure to DEM; in lanes 3 and 7 and lanes 4
and 8, unbound or eluted cRI, respectively, after exposure to 100 or
500 lM DEM. Intensity of the bands was revealed at the phosphor-
imager.with respect to wild type cells (see Table 1). In HUVE cells,
with a higher content of endogenous cRI and a low GSH con-
tent, upon transfection the GSH level became so low that it
could not be detected (see Table 1).
We also determined the levels of free thiols and protein thi-
ols in the cells under investigation. We found (see Table 1) that
for HeLa cells, both wild-type and cRI silenced, cRI depriva-
tion engendered a severe drop in the content of small thiol
compounds, whereas no signiﬁcant eﬀects were detected for
the level of protein thiols. Given the very low levels of GSH
in wild-type HUVE cells, the assay was deemed to be not per-
tinent in the corresponding cRI-silenced cells.
Hence, in cells deprived of cRI a decrease of the content of
GSH and other small thiol compounds occurs, clearly a signal
of the altered redox environment resulting from the decrease or
absence of an eﬀector, such as cRI, which with its high content
of Cys residues contributes to protect the cell from oxidative
damage. These results assign to cRI a signiﬁcant antioxidant
role. Furthermore, the ﬁnding that wild-type HUVE cells con-
tain high levels of inhibitor, but extremely low levels of GSH,
suggests that a balanced pool of thiol-rich molecules, such as
cRI and GSH, is present in the cell, whose common role would
be an interplay to keep homeostasis through redox ‘‘buﬀering’’.
3.3. Response of HeLa cells to redox treatments after cRI
silencing
It has been established that oxidative stress generates DNA
damage [13,14]. Since the redox intracellular environment was
found to be altered in cRI deprived cells, we analyzed the
eﬀects of cRI silencing on DNA integrity and its interference
with GSH homeostasis.
Fig. 3 shows the results of the determination of the GSH
content and a Comet analysis of HeLa cells treated, before
and after cRI silencing, with DEM as an oxidant, or N-ace-
tyl-cysteine (NAC) as a GSH biosynthetic precursor, or a com-
bination of these agents. Even in the absence of any treatment
we found that cRI silencing not only led to decreased GSH lev-
els, but also to a marked increase of DNA damage (Fig. 3,
panels A and B). A good correlation between DNA damage
and GSH levels was observed also when the eﬀects of DEM
were analyzed, as DEM induced both a marked GSH deple-
tion (Fig. 3A) and longer comet tails (Fig. 3B). These eﬀects
were more marked in cRI-deprived cells. Exposure to NAC,
alone or before treatment with DEM, prevented oxidant-in-
duced toxic eﬀects in both wild-type and cRI-deprived cells.
These results conﬁrm that cRI-deprived cells are more sensitive
to oxidative insults and reinforce the hypothesis of a cellular
role of cRI in the prevention of oxidative damages.
3.4. Response of HUVE cells to redox treatments after cRI
interference
In HUVE cells cRI deprivation leads to the virtual disap-
pearance of cellular GSH (see Table 1). Thus, the eﬀects of
Fig. 3. Eﬀects of redox treatments on GSH content and DNA damage
in wild-type (grey bars) and cRI-deprived (black bars) HeLa cells. Cells
were treated with either NAC (5 mM), or DEM (0.5 mM) or their
combination. Cellular response to these treatments was analyzed
measuring GSH content (Panel A) and DNA damage by the comet
assay (Panel B).
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gated. On the other hand, in HUVE cells cRI silencing wasFig. 4. Eﬀects of redox treatments on wild type and cRI-deprived
HUVE cells. Panel A: Cell survival before (black bars) and 72 h after
transfection with pU6-cRI-neor plasmid (grey bars) in cells untreated
or treated with 40 lMDEM. Panel B: analyses of DNA damage by the
Comet assay carried out on wild-type (black bars) and cRI-deprived
(grey bars) HUVE cells. Cells were treated with DEM or NAC, or their
combination, as in Fig. 3.obtained only in a transient mode (see above). Thus, we pre-
liminarily tested the eﬀects of cRI deprivation on cell survival.
We observed that 72 h after transfection cell survival was scar-
cely aﬀected, as more than 70% of cells survived (Fig. 4A).
DEM as an oxidant was found to display by itself a cytotoxic
eﬀect, but this was signiﬁcantly higher on cRI deprived cells
(Fig. 4A).
These ﬁndings could be clearly related to the cells redox sys-
tem [13,14], as DEM was found also to induce a strong in-
crease of DNA damage, especially on cRI-deprived cells, an
eﬀect prevented by NAC (see Fig. 4B). These results are in line
with the preceding results obtained with the HeLa cells system,
and conﬁrm the important role of cRI in the cellular defense
against redox stress.4. Conclusions
As outlined in Section 1, there are doubts that the cellular
role of the cytosolic RNase inhibitor is merely that of an
RNase inhibitor. It has been suggested instead that this pro-
tein, with its high content of cysteine residues (32 over 460
amino acids), has an antioxidant function in the cell, as cells
overexpressing cRI become more resistant to H2O2 [8,9], and
a scavenging activity of cRI on oxygen radicals has been
reported [9].
We veriﬁed this hypothesis with a radically diﬀerent strategy,
by treating engineered malignant HeLa cells, and primary
endothelial HUVE cells, partially or totally deprived of cRI
expression, with oxidants or anti-oxidants. Our results demon-
strate that GSH levels are decreased in cRI-deprived cells, a
signal of an inadequate redox intracellular environment engen-
dered by the lack of cRI as an antioxidant agent. In fact, a gen-
eral perturbation of the redox balance toward oxidative
conditions was conﬁrmed by the decreased thiol levels deter-
mined in cRI-deprived cells. As a consequence, cRI-deprived
cells were found to become more sensitive to DEM-induced
DNA damage.
In summary, the results presented here strongly support the
hypothesis that in the cell, besides the tri-peptide GSH, a
‘‘giant’’ GSH is also present, the cytosolic RNase inhibitor,
with the role of a ‘‘sentry’’ towards oxidative stresses to main-
tain a well buﬀered intracellular redox environment.
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